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Abstract: Asymmetrical flow field-flow fractionation (AF4) separates sample components based on
their sizes in the absence of a stationary phase. It is well suited for high molecular weight samples
such as virus-sized particles. The AF4 experiment can potentially separate molecules within a broad
size range (~103−109 Da; particle diameter from 2 nm to 0.5−1 µm). When coupled to light scattering
detectors, it enables rapid assays on the size, size distribution, degradation, and aggregation of
the studied particle populations. Thus, it can be used to study the quality of purified viruses and
virus-like particles. In addition to being an advanced analytical characterization technique, AF4 can
be used in a semi-preparative mode. Here, we summarize and provide examples on the steps that
need optimization for obtaining good separation with the focus on virus-sized particles.
Keywords: virus; virus-like particle; field-flow fractionation; size-based separation; macromolecular
complex; virus purification; light scattering
1. Short Introduction to Asymmetrical Flow Field-Flow Fractionation
In asymmetrical flow field-flow fractionation (AF4), sample components are separated in a
trapezoid-shaped flat channel using the forces generated by two simultaneous flows, as follows: The
channel flow (Vout) and the cross flow (Vc) (Figure 1a). The channel has a permeable bottom plate
and an impermeable see-through top plate (Figure 1a), which are separated by a spacer with a typical
width of 250−500 µm (Figure 1b). The porous bottom plate is layered with an ultrafiltration membrane
of desired material and molecular-weight cut-off (MWCO), determining the lowest size limit for
sample components that are retained in the channel. The membrane and the bottom plate form the
accumulation wall. The laminar flow passing through the channel has a parabolic profile with the
flow velocities being the highest in the center and the slowest at the channel walls (Figure 1a). AF4
has a focusing and an elution step. Sample injection takes place during the focusing step; whereas
size-based separation occurs during elution (see Section 2.5). One of the benefits of AF4 is that the
separation takes place without the use of stationary phase. This avoids mechanical and shear stress
that could cause entanglement and alterations in the native conformation of studied biomaterial.
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coefficients. Therefore, smaller particles experience the higher velocity flow in the central region of 
the channel and elute first (Figure 1a). For particles that have diameters larger than ~1 µm, diffusion 
away from the accumulation wall is negligible and elution proceeds from larger to smaller sample 
components. Such reverse elution order (steric elution mode) can take place for rod-shaped particles, 
if the ratio of the longitudinal axis and the diameter is high [6] and is thus possible for rod-shaped 
and filamentous viruses. There is no upper molar mass limit in AF4 separation [7]. Detailed 
description of the AF4 principles, theory, and applications can be found from many available reviews 
and textbooks [4,7–13]. Although other sub-techniques of field-flow fractionation, such as centrifugal 
(or sedimentation) field-flow fractionation or electrical field-flow fractionation show great potential 
for virus-related studies, here we focus on AF4. 
 
Figure 1. (a) Principle of asymmetrical flow field-flow fractionation (AF4). Cross flow forces the 
sample components towards the accumulation wall, which consists of an ultrafiltration membrane 
layered on top of a permeable ceramic frit through which the cross-flow is pumped out. Sample 
components diffuse against the cross-flow force depending on their diffusion coefficients that are size-
dependent. Channel flow that moves through the channel has the highest velocity in the middle of 
the channel. It transports sample components towards the detectors. Small sample components reach 
the highest velocities and elute first. In practice, the sample components occupy ~1% of the total 
channel thickness (w) and the rest of the flow is sample free. Virus particles are not drawn to scale. 
(b) Channel shape, length (L), maximum breadth (bmax), and nominal thickness (w, see a) are 
determined by the spacer. Due to the spacer design, the breadth of the channel decreases linearly 
towards the outlet end of the channel. Commercial spacers for standard analytical (top) and semi-
preparative (bottom) AF4 channels from Postnova are shown. 
The most common online detectors coupled to AF4 are multi angle light scattering (MALS), 
dynamic light scattering (DLS), ultraviolet (UV), and refractive index (RI) detectors. However, for 
instance, fluorescence detectors can provide valuable information on components tagged with 
fluorescent proteins or labels. Light scattering detectors enable the determination of the radius of 
gyration (Rg—MALS), radius of hydration (Rh—DLS), shape factor (Rg/Rh), and polydispersity index. 
Combination of the data obtained from the concentration (UV, RI) and light scattering detectors 
enables the collection of data on molecular weight (Mw) distribution. However, AF4 theory can also 
be utilized to calculate hydrodynamic diameter (dH) based on the retention time (tr) obtained with the 
applied experimental parameters, provided that constant cross flow has been applied and conditions 
providing high retention are used (see 2.4.) (Figure 2). If cross-flow gradients are used, dH can be 
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Separation of sample components is affected the most by the applied external field—the cross-flow.
It is perpendicular to the channel flow and pushes the sample components towards the accumulation
wall. This force is counteracted by diffusion of molecules away from the wall (Figure 1a). As a result,
each sample component equilibrates at a distance from the accumulation wall that depends on the
diffusion coefficient (D) and the hydrodynamic diameter (dH) of the studied sample [1,2], as well as
the applied fractionation conditions (Figure 2). Normal elution mode applies to sample components
that are smaller than ~0.5−1 µm in diameter [3–5] and are valid for most viruses and virus-like
particles (VLP). In normal elution mo e, large sample components with small diffusion coefficients
equilibrate closer to the accumulation wall than do small particles with large diffusion coefficients.
Therefore, smaller particles experience the higher velocity flow in the central region of the channel and
elute first (Figure 1a). For particles that have diameters larger than ~1 µm, diffusion away from the
accumulation wall is negligible and elution proceeds from larger to smaller sample components. Such
reverse elution order (steric elution mode) can take place for rod-shaped particles, if the ratio of the
longitudinal axis and the diameter is high [6] and is thus possible for rod-shaped and filamentous
viruses. There is no upper molar mass limit in AF4 separation [7]. Detailed description of the AF4
principles, theory, and applications can be found from many available reviews and textbooks [4,7–13].
Although other sub-techniques of field-flow fractionation, such as centrifugal (or sedimentation)
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field-flow fractionation or electrical field-flow fractionation show great potential for virus-related
studies, here we focus on AF4.
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components and making a calibration curve between dH and tr . Finally, molecular mass and volume 
information can be used to calculate the apparent density of the studied sample components. 
 
 
Figure 2. Retention time (tr) depends on the diffusion co-efficient of the analyzed sample, which 
correlates with the hydrodynamic diameter (dH). Several parameters affect retention time and have 
inter-dependent effects. In general, cross flow (Vc) has the strongest impact on separation. Void time 
(t0) and void volume (V0) are dependent on the channel thickness (w), whereas diffusion and eluent 
viscosity are temperature-dependent. In addition, the eluent, channel geometry, and the channel-flow 
rate affect retention time. 
The field-flow fractionation technique was introduced in 1976 with self-made instrumentation 
[14]. One of the first studies reported the use of symmetric field-flow fractionation with two 
accumulation walls to determine the diffusion coefficients of bacteriophages Qβ, f2, MS2, P22, and 
ϕX174 [1]. The potential of field-flow fractionation for separating, identifying, purifying, 
quantitating, and characterizing viruses was recognized already then.  
Virus and VLP preparations purified to near homogeneity are essential to fundamental basic 
virology but also to several biotechnological, nanotechnological, and medical applications. Large 
macromolecular complexes such as viruses, VLPs, and their subassemblies, however, are challenging 
objects to purify. Furthermore, particles that are intended for vaccination or gene therapy need to be 
pure, stable, homogenous in size, and devoid of aggregates. Same quality requirements also apply 
for many biochemical and structural studies of viruses and VLPs. The benefits and challenges of AF4 
are summarized in Table 1 and discussed below. We summarize the current works where commercial 
AF4 equipment from Wyatt and Postnova have been applied to study viruses and VLPs. We also 
provide examples on the effect of experimental parameters on AF4 fractionation of an enveloped 
bacteriophage ϕ6 with diameter of ~70 nm [15] on a standard analytical AF4 channel using the 
Postnova instrument (Figures 3-6).  
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• Gentle non-invasive technique.  
• Automation in injection and fraction collection. 
• Adjustable mobile phase composition. 
• Size-based separation. 
• Short analysis time. 
• Typically high recovery yields. 
• High repeatability between injections. 
• Wide size range for separation in a single AF4 
experiment.  
• Easy coupling to various in-line detectors (UV, 
MALS, DLS, fluorescence). Easy fraction collection 
for off-line analysis. 
• Tedious optimization. 
• Inter-dependent effects of experimental 
parameters on retention behaviour. 
• Not routinely available. 
• Potential mixing of normal and steric elution 
modes if the analyzed sample has high 
polydispersity in the size range. 
• Potential membrane interactions with sample 
components. 
• Sample-sample interactions if high sample 
loads or high cross-flow rate is applied.  
Figure 2. Retention time (tr) depends on the diffusion co-efficient of the analyzed sample, which
correlates with th hy rodynamic di meter (dH). Several parameters affect retention time and have
inter-dependent effects. In general, cross flow (Vc) has the strongest impact on separation. Void time
(t0) and void volume (V0) are dependent on the channel thickness (w), whereas diffusion and eluent
viscosity are temperature-dependent. In addition, the eluent, channel geometry, and the channel-flow
rate affect retention time.
The most common online detectors coupled to AF4 are multi angle light scattering (MALS),
dynamic light scattering (DLS), ultraviolet (UV), and refractive index (RI) detectors. However,
for instance, fluorescence detectors can provide valuable information on components tagged with
fluorescent proteins or labels. Light scattering detectors enable the determination of the radius of
gyration (Rg—MALS), radi s of hydr tion (Rh—DLS), shape factor (Rg/Rh), and polydispersity index.
Combination of the data obtained from the concentration (UV, RI) and light scattering detectors
enables the collection of data on molecular weight (Mw) distribution. However, AF4 theory can also be
utilized to calculate hydrodynamic diameter (dH) based on he retention time (tr) obtained with the
applied experimental parameters, provided that constant cross flow has been applied and conditions
providing high retention are used (see Section 2.4) (Figure 2). If cross-flow gradients are used, dH
can be determined by performing AF4 analysis with standards that cover the sizes of studied sample
components and making a calibration curve between dH and tr. Finally, molecular mass and volume
information can be used to calculate the apparent density of the studied sample components.
The field-flow frac nation technique was ntroduced in 1976 with self-made instrumentation [14].
One of the first studies reported the use of symmetric field-flow fractionation with two accumulation
walls to determine he d ffusion coefficients of bacteriophages Qβ, f2, MS2, P22, and φX174 [1].
The potential of field-flow fractionation for separating, ide tifying, purifying, quantitating, and
characterizing virus s was recognized already then.
Virus and VLP preparations purified to near h geneity are essential to fundamental basic
virology but also to seve al biotechnol gical, anotechnological, and medical applications. Large
macromolecular complexes such as viruses, VLPs, and their subassemblies, however, are challenging
objects to purify. Furthermore, particles that are intended for vaccination or gene therapy need to be
pure, stable, homogenous in size, and devoid of aggregates. Same quality requirements also apply for
many biochemical and structural studies of viruses and VLPs. The benefits and challenges of AF4 are
summarized in Table 1 and discussed below. We summarize the current works where commercial AF4
equipment from Wyatt and Postnova have been applied to study viruses and VLPs. We also provide
examples on the effect of experimental parameters on AF4 fractionation of an enveloped bacteriophage
φ6 with diameter of ~70 nm [15] on a standard analytical AF4 channel using the Postnova instrument
(Figures 3–6).
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Table 1. Advantages and challenges of AF4 in virus and virus-like particle (VLP) applications.
Advantages Challenges
• Gentle non-invasive technique.
• Automation in injection and fraction collection.
• Adjustable mobile phase composition.
• Size-based separation.
• Short analysis time.
• Typically high recovery yields.
• High repeatability between injections.
• Wide size range for separation in a single
AF4 experiment.
• Easy coupling to various in-line detectors (UV,
MALS, DLS, fluorescence). Easy fraction
collection for off-line analysis.
• Various membrane materials available with
different MWCO.
• Membrane-selective AF4 to remove components
that are smaller than the membrane MWCO.
• Up to ~50 injections can be analysed with a
single membrane.
• Slot flow pump option to remove the
sample-free eluent.
• Semi-preparative and mini channels to
preparative applications and analysis of
scarce samples.
• Sample pre-processing not required.
• Relatively cheap running costs.
• Tedious optimization.
• Inter-dependent effects of experimental
parameters on retention behaviour.
• Not routinely available.
• Potential mixing of normal and steric elution
modes if the analyzed sample has high
polydispersity in the size range.
• Potential membrane interactions with
sample components.
• Sample-sample interactions if high sample loads
or high cross-flow rate is applied.
• Lot-to-lot variation in membranes and
between manufacturers.
• Sample dilution during fractionation.
• Small sample loads in standard analytical AF4.
• High initial investment costs.
• Expensive detectors.
2. It Depends on Conditions: AF4 Parameters Affecting Separation
AF4 method optimization is done according to the largest sample component that is being
analyzed. In general, AF4 theory-based predictions and literature provide a good starting point for
methods development. Importantly, the experimental parameters have a complex inter-dependency
(Figure 2) and the conditions may need to be re-adjusted several times. However, the obtained
results are typically highly repeatable. We have collected the experimental conditions utilized for AF4
studies of VLPs and viruses in Tables 2 and 3, respectively. Whether AF4 is aimed to be utilized for
high-resolution size-separation or as a method to obtain a maximal amount of sample for downstream
applications determines the critical points for AF4 method development.
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Table 2. Summary of AF4 studies on VLPs and the AF4 operation conditions used.
Virus 1) Specimen Analysis/Study
Membrane
3)
MWCO,
kDa
Spacer,
µm Channel
4) VC Gradient
5) VC, Start VC, End VOUT
Total Analysis
Time 6) (min) Eluent Reference
EV71,
CVA16
VLPs (Ø ~30
nm) Quality
2), yield RC 10 350 S C 1.0 0 1.2 50 (6 + 30)
50 mM
Tris-glycine (pH
7.4), 150 mM NaCl
[16]
HBV
(HBsAg)
VLPs (Ø
~23–29 nm)
Quality, salt
induced
aggregation,
stability
RC 10 350 S C+L 1.0 1.0 1.0 55 (5 + 40 + 5 + 5) 20 mM phosphatebuffer (pH 7.4) [17,18]
MPV
VLPs (VP1)
(Ø ~40–60
nm)
VLP
characterization:
in vitro and
in vivo
assembled, VC
optimization,
sample load
RC 10 350 S C+L 0.75 0 0.75 ~60 (10 + 30)
10 mM Tris-HCl
(pH 8.0), 50 mM
NaCl, 10 mM
CaCl2 or 20 mM
Tris-HCl (pH 7.4),
200 mM NaCl, 1
mM CaCl2, 5%
(v/v) glycerol
[19]
MPV
Disassembled
VLPs,
pentamers
Quality As in [19].
40 mM Tris-HCl
(pH 8.0), 200 mM
NaCl, 1 mM
EDTA, 5 % (v/v)
glycerol, 5 mM
DTT
[19,20]
MPV VLPs
Size and size
distribution:
effect of affinity
tags on VP17)
and VP2, effect
of packaged
DNA or VP2.
Method
validation8)
As in [19].
10 mM Tris (pH
8.0), 50 mM NaCl,
0.01 mM CaCl2
[21,22]
MPV
In vitro
assembled
VLPs (VP1)
Quality As in [19].
40 mM Tris (pH
7.2 or 8.0), 200 mM
NaCl, 5% (v/v)
glycerol, 0.05 or
0.2 mM CaCl2
[20]
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Table 2. Cont.
Virus 1) Specimen Analysis/Study
Membrane
3)
MWCO,
kDa
Spacer,
µm Channel
4) VC Gradient
5) VC, Start VC, End VOUT
Total Analysis
Time 6) (min) Eluent Reference
MPV VLPs
VLP
formulation,
stability,
aggregation,
effect of affinity
tags (VP1)
As in [19]. PBS (pH 7.4)9) [23]
MPV
In vitro
assembled
VLPs, VP1
capsomers
(wild type
and
modified)
Formulation of
efficient in vitro
assembly
reaction, VLP
quality, recovery
As in [19]. PBS (pH 7.4) [24]
JCV
VLPs (Ø ~40
nm) and VP1
pentamers
VLP quality,
optimal
production,
effect of
packaged DNA,
dissociation
RC 10 350 S C+L 0.75, 1.0,1.5 0
0.75 or
1.0
50 (10 + 20–35 +
1–5)
VLPs: 20 mM
Tris-HCl (pH 7.5),
50/150 mM NaCl.
VP1 Pentamers:
280 mM NaCl, 1
mM EGTA, 5 mM
DTT
[25]
JCV VLPs
VLP quality,
optimal
production
conditions
RC 10 440 S L 1.5 0 0.5 50 (10 + 25)
20 mM Tris-HCl
(pH 7.5), 150 mM
NaCl
[25]
Qβ,
NicQβ VLPs
Optimization
(membranes,
flow rates,
focusing time).
VLP (3.5 MDa)
quality &
stability.
Method
validation8)
RC (PES,
CA) 10 350 S C+L+L 2.0 0.15, 0 1.5 56 (8 + 18 + 15 + 5)
20 mM Na
phosphate buffer
(pH 7.0), 150 mM
NaCl
[26,27]
Qβ VLPs VLP quality RC 10 350 M C+L 1.0 0 1.2 31 (6+14+5) As above [26]
1) Virus abbreviations: EV71, enterovirus 71; CVA16, coxsackie virus A16; HBsAg, hepatitis B surface antigen; JCV, human polyoma JC virus; MPV, murine polyoma virus, NicQb, VLPs of
bacteriophage Qβ that wears covalently linked nicotine haptens. 2) Quality: Molar mass, size, size distribution, heterogeneity, presence of aggregates, oligomers, degradation products. 3)
RC, regenerated cellulose; CA, cellulose acetate; PES, polyether sulfone. 4) Channel type: S, standard analytical channel (length ~26 cm); M, mini channel (length ~18 cm). 5) Cross-flow
gradient types: C, constant cross-flow rate; L, linear cross-flow gradient. Typical elution programs also utilize rinse periods without applied cross flow at the end of the run (not indicated in
the table). 6) Total analysis time is dependent on the time that the analysis is continued after the cross flow has ceased to 0 mL/min. In many of the publications this is not clearly indicated.
Focusing and injection time and the length of elution gradient are given in parenthesis. 7) VP, viral protein 8) Method validation: AF4-MALS compared to electrospray differential mobility
analysis and transmission electron microscopy (MPV) or size exclusion chromatography and dynamic light scattering (Qβ). 9) PBS, phosphate buffered saline (pH 7.4).
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Table 3. Summary of AF4 studies on viruses and used operation conditions for standard analytical channel.
Virus 1),
Diameter, nm 2)
Specimen Analysis/Study 3)
Membrane
3)
MWCO,
kDa (kDa)
Spacer,
µm
VC
Gradient 4) VC, Start VC, End VOUT
Total Analysis
Time 5) (min) Eluent Reference
Influenza(~113) Crude andpurified viruses
AF4 method
optimization.
Polydispersity, effect of
purification and
excipient addition, virus
particle counts. Method
validation 6)
RC 10 350 L 0.4 or 0.6 0 0.8–1.0 ~50–75 (15 + 35–60) 0.1 M K-phosphate (pH7.4) [28]
Influenza, AdV Purified viruses Aggregation and virusconcentration RC, CA 10 350 L n.d.* n.d. 1.0 ~25–35
Influenza aqueous,
AdV 10% (v/v) glycerol [29]
Influenza
Purified viruses,
culture
supernatants
Quantitation and
sensitivity, size
distribution
PES 10 350 L 0.3 0 1.0 ~60 (35)
0.01 M
Na-/K-phosphate (pH
7.4), 0.14 M NaCl
[30]
T4, MS2, Y1, C2
(~25–110) Purified viruses
Effect of viruses on
optical backscattering in
oceans: refractive index
calculations
RC 10 n.d. C 0.92 0.92 1.9 n.d.
PBS (pH 7.2) or boric
acid-buffered saline
(pH 9.5), 0.1 % (v/v)
Pluronic F68
[31]
PRD1(~63)
Culture
supernatants,
PEG-precipitate,
purified viruses
Virus purification: AF4
method optimization,
sample load, quality,
progress of infection
RC 100 350, 250 L, L+E 1.0 0.1 0.2, 0.5 ~60(5–15 + 25–45) 20 mM K-phosphate(pH 7.2), 1 mM MgCl2
[32]
His1, HRPV1,
HVTV-1, HCIV-1
(~40–100)
Culture
supernatants,
PEG-precipitate,
purified viruses
Virus purification: yield,
quality 7), progress of
infection (His1)
RC 100, 10 350, 250 L, L+E 1.0 0.1 0.2, 0.5 ~60 (5–15 + 25–45)
20–50 mM Tris-HCl
(pH 7.2–7.5), 0.5–1.5 M
NaCl, 35–100 mM
MgCl2, 1–2 mM CaCl2,
± 10–28 mM KCl, ±47
mM MgSO4
[33]
φ6(~71)
Culture
supernatants,
PEG-precipitate,
purified viruses
Virus purification: yield,
quality RC 100, 10 350, 250 L, L+E 1.0 0.1 0.2, 0.5 ~60 (5–15 + 25–45)
20 mM K-phosphate
(pH 7.2), 1 mM MgCl2
[34]
φ6 Purified viruses
Virus disassembly,
purification of functional
subassemblies
RC 10 250 C+L 1.0 0.1 0.2 ~50 (5–10 + 5+25)
10 mM K-phosphate
(pH 7.2), 1 mM MgCl2,
±0.1 mM CaCl2, ±150
mM NaCl, ±20 mM
EGTA
[35]
* N.d. not determined. 1) Virus name abbreviations: AdV, adenovirus; HVTV-1, Haloarcula vallismortis tailed virus 1; HRPV-1, Halorubrum pleomorphic virus 1; HCIV-1, Haloarcula
californiae icosahedral virus 1; T4, MS2, Y1, C2, PRD1, φ6 are bacteriophages. 2) Dgeo = geometric diameter calculated from AF4-MALS derived root mean square radius assuming
homogenous or hard spheres or obtained from transmission electron microscopy. For tailed phages, the diameter refers to the capsid (head) size. For pleomorphic viruses the size range of
the smallest and largest dimension is given. 3) RC, regenerated cellulose; CA, cellulose acetate; PES, polyether sulfone. 4) Cross-flow gradient type: C, constant cross flow; L, linear
cross-flow gradient; E, exponential cross-flow gradient. Typically, elution ends with a rinsing period without applied cross flow. Rinse periods are not indicated in the column. 5) Total
analysis time is dependent on the time that the analysis is continued after the cross flow has ceased to 0 mL/min. In many of the publications this is not clearly indicated. Focusing and
injection time and the length of elution gradient is given in parenthesis. 6) Method validation: Comparison of AF4-MALS to size-exclusion chromatography coupled to MALS; transmission
electron microscopy; atomic force microscopy: median tissue culture dose; fluorescent focus assay; reverse transcription polymerase chain reaction. 7) Quality= molar mass, size, size
distribution, purity, heterogeneity, aggregation, and number of infectious viruses.
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2.1. Channel Dimensions
Sample components are separated in a channel. Its shape, length, breadth, and thickness is
defined by the used spacer (Figure 1b). Spacer thickness affects separation (Figure 2). Thin spacers
shorten the analysis time, and reduce eluent consumption as well as sample dilution due to decreased
channel volume [36], whereas thicker spacers provide better separation and may enable higher sample
loads [7,13,37]. The effect of 250 and 350 µm spacers on elution of bacteriophage φ6 in the standard
analytical channel is exemplified in Figure 3a. The use of a thinner spacer promotes virus elution at a
higher cross-flow rate, enabling its separation from larger sample components. In general, most virus
and VLP works have utilized the 350 µm spacer, but there are also examples where the 250 or 500 µm
spacers have been used (Tables 2 and 3).
Standard analytical channels (~27 cm long, maximal breadth of ~2−2.5 cm; Figure 1b, top) are
best suited for analytical purposes due to the limited loading capacity, which is typically below
~0.1 mg. Sample loads can be increased to some extent by using thicker spacers, or by optimizing the
focusing site at the point of maximal channel breadth [37] (Figure 1b). The injected sample amount
can be increased up to the point where symmetrical elution peaks with unaltered retention times are
still obtained. For pre-purified bacteriophage PRD1 sample, the working range using the standard
analytical channel and the 350 µm spacer is between ~3 µg and ~3 mg, corresponding to ~109−1013
plaque forming units (PFU) [32]. However, when milligram amounts are loaded, the peaks become
broadened and skewed, indicating overloading and nonoptimal separation. In general, the applicable
loading amount depends on sample concentration, used AF4 parameters, channel dimensions, and
sample properties affecting the viscosity of solutions [38], and is typically lower for heterogeneous
virus samples compared to purified ones [32–34]. Consequently, AF4 purification of viruses directly
from cleared cell lysates yields some tens of micrograms per mL of injected lysate [32,34], but the
potential yields are obviously highly dependent on the virus and the corresponding production system.
In preparative approaches, the limits of the standard analytical channels can be compensated
by making several AF4 fractionations in a row, which is feasible due to the short analysis time (see
Figure 3b for example). However, the best option is to use semi-preparative channels with increased
maximal breadth at the inlet end (Figure 1b, bottom), while increasing the channel length has little
effect on the loading capacity [37]. Semi-preparative channels with a maximum breadth of 5 or 10
cm have been used to separate milligram quantities of solid silica spheres with diameters of 50 and
100 nm [37] and liposomes with mean diameters of ~70 and ~300–400 nm [39].
Miniaturized channels with reduced dimensions enable rapid analysis, resulting in increased
sample throughput. In addition, less sample and eluent is consumed [26]. For example, miniaturized
~18 cm long channels enabled the analysis of VLP oligomerization state from one fourth of the sample
amount compared to the standard channel [26].
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that influences retention time. (c) The ionic strength of the eluent affects retention time via its influence 
on the electrostatic interactions between the sample components, and the sample components and the 
membrane. (d) Decreased channel temperature slows down diffusion and retards elution. Cross-flow 
gradients are shown with black dashed lines (right y-axis). Transition from focusing to elution is 
indicated with an arrow. UV detector response is given in volts (V) (left y-axis). Eluent was 20 mM 
potassium phosphate buffer (pH 7.2), 1 mM MgCl2. NaCl concentration of eluent (if present), channel 
flow rate (Vout), void peak (V0), injected virus amounts (PFU), and membrane MWCO are indicated in 
the corresponding panels. A spacer with a 250 µm nominal thickness was used in b–d. The AF4 
instrument used was from Postnova and its operation is described in [32]. ϕ6 was pre-purified with 
polyethylene glycol precipitation and two subsequent ultracentrifugations [34], Appendix 1. 
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Figure 3. Effects of instrumental parameters on AF4 separation of enveloped bacteriophage φ6.
(a) Thinner spacer advances elutio (spacers of 250 and 350 µ i orange and blue, respectively).
(b) Adsorptio of sample c mponents on membrane surface cau es membrane fouling (membrane
aging) that influences retention time. (c) The ionic strength of the eluent affects retention time via its
influence on the electrostatic interactions between the sample components, and the sample components
and the membrane. (d) Decreased channel temperature slows down diffusion and retards elution.
Cross-flow gradients are shown with black dashed lines (right y-axis). Transitio from focusing to
elution is indicated with an arrow. UV detector response is given in volts (V) (left y-axis). Eluent was
20 mM potassium phosphate buffer (pH 7.2), 1 mM MgCl2. NaCl concentration of eluent (if present),
channel flow rate (Vout), void peak (V0), injected virus amounts (PFU), and membrane MWCO are
indicated in the corresponding panels. A spacer with a 250 µm nominal thickness was used in b–d. The
AF4 instrument used was from Postnova and its operation is described in [32]. φ6 was pre-purified
with polyethylene glycol precipitation and two s bsequent ult acentrifugations [34], Appendix A.
2.2. Ultrafiltration Membran
Ultrafiltration membrane chemistry including its charge, MWCO, hydrophobicity and
hydrophilicity, as well s the eluent comp sition, and the properties of th studied sample components
affect the applicable flow rates, recoveries, and retention behavior [7,40,41]. Interactions between the
sample components and the membrane are the point of potential failure in AF4. Attractive interactions
increase the retention time, whereas repulsive interactions reduce it. However, the surface area for
potential adso ption is small and thus the recoveries are gen ra ly good. Large rod-shaped sample
components have a bigger interactive surface area than small and spherical particles and, thus, they are
more prone to interact with the membrane. Regenerated cellulose (RC) with MWCO of 10 kDa is most
frequently used for viruses and VLPs, but polyethersulfone (PES) membranes are also occasionally
utilized (Tables 2 and 3). For example, higher recovery of bacteriophage QβVLPs was obtained with RC
than with PES or cellulose triacetate (TCA) membranes [26]. Accumulation of sample components on
the membrane can decrease peak intensity and induce small changes in the retention time. This is often
most evident among the first experiments/injections with a new membrane and more evident for low
sample loads [42]. The effect of membrane fouling/aging is illustrated in Figure 3b. Sample-membrane
interactions can be minimized by first running small amounts of the sample or inert protein, such as
bovine serum albumin, to condition the membrane. Depending on the sample, up to ~50 injections can
be analyzed with a single membrane.
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Membrane MWCO can be selectively chosen to remove sample components that are smaller than
the pores of the membrane. For example, sugars and peptides of culture media can be efficiently
separated from the viruses by utilizing membrane with MWCO of 100 kDa [32–34]. Importantly,
membrane MWCO affects the cross-flow rate that can be used, as follows: Higher MWCO allows
higher cross-flow rates.
The membrane part that aligns beneath the spacer becomes compressed and intrudes into the
channel. Thus, the actual channel thickness is smaller than the nominal value of the spacer. The actual
measure for the channel thickness is crucial for accurate hydrodynamic size calculations (Figure 2) and
it can be determined experimentally. Importantly, the experimentally determined channel thickness is
only valid when the same experimental conditions are used [43]. Furthermore, compression tendency
of the membrane depends largely on the backing of the membrane, and it is manufacturer and lot
dependent [7,43]. Consequently, a change in the membrane lot can have an impact on the obtained
separation and retention time.
2.3. Eluent and Channel Temperature
Eluent impacts resolution and yield. One of the benefits of AF4 is the flexibility to adjust the
eluent composition, although for viruses and VLPs this is often limited to eluents that keep them
biologically intact (Tables 2 and 3). For therapeutics, some additional limits might arise from the
intended applications. The eluent can also be intentionally modified to promote the assembly or
disassembly of virions and VLPs during AF4 separation (see below). The chosen eluent needs to be
compatible with the selected membrane.
The ionic strength, pH, and the presence of surfactants influence the net charge of the sample
components and the membrane. Consequently, either attractive or repulsive sample-sample or
sample-membrane interactions can take place. At neutral pH, most ultrafiltration membranes have
negative charge [44]. The ionic strength of the eluent affects retention time and peak width. At very
low ionic strength, the electronic double layers formed around the sample components are thick [45].
This may advance elution, since sample components equilibrate farther from the accumulation wall
and have access to higher flow velocities in the channel (Figure 1a). Increasing the ionic strength of the
eluent helps to shield attractive electrostatic forces and can reduce peak broadening that is caused
by electrostatic repulsion between the sample components. The effect of increased ionic strength on
elution of bacteriophage φ6 is exemplified in Figure 3c. Importantly, too high ionic strength results
in a very thin electronic double layer, sample components equilibrate close to the accumulation wall,
electrostatic repulsion becomes negligible, and hydrophobic and other short-range interactions such
as van der Waals forces start to dominate [45]. This potentiates low recovery, high retention, and
aggregation. However, AF4 has been successfully used to purify viruses using eluents of high, up to
1.6 M, total ionic strength (see Section 3.1) [33].
Channel temperature influences the separation due to its effects on diffusion and eluent viscosity
(Figures 2 and 3d). In some applications, lower temperatures may be preferred to inhibit proteolytic
degradation or to maintain virion integrity (e.g., viruses of psychrophiles adapted to low temperatures)
during AF4.
2.4. Separation Efficiency, Retention Time, Retention Level and Resolution
In AF4, flow conditions are adjusted to result in short retention times, and thus a short total
analysis time. Retention level is determined as the ratio of retention time of the peak of the studied
specimen (tr) and that of the void peak (t0). It affects separation, resolution, width of the peaks, and
analysis time and is thus an important part of AF4 method development [13,46]. A retention level
≥5 indicates strong retention [7]. The higher the value, the narrower the peaks usually are, the more
homogenous the peak content will be, and the more accurate the obtained size estimates are [13].
Retention level can be adjusted by altering instrumental parameters such as flow rates. For example,
an increased cross-flow to channel-flow rate increases retention time and, thus, the retention level [13].
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Higher retention level can also be achieved by using thicker spacers. For virus-sized particles, adequate
retention levels are typically easily achieved, since hydrodynamic diameter positively correlates with
the retention level [13]. Retention level values ≥30 are not recommended as the analysis time will be
unreasonable long [7,13,46].
For heterologous and complex samples, resolution between the peaks is also important. Resolution
between two peaks (RS) is calculated from the differences in their retention times divided by the
average of peak base widths (RS = ∆t/wb). Complete resolution is obtained if the RS value is ≥1.5.
Resolution can be improved by increasing the cross-flow and channel-flow rates while keeping their
ratio constant. This should result in the same retention time but in more narrow peaks [13].
In principle, a single AF4 experiment can separate molecules with a broad size range (~103−109 Da,
particle diameter from 2 nm to 0.5−1 µm) [5]. Baseline separation can be achieved with sample
components having ~twofold size difference. This is exemplified in Figure 4, where separation of
bacteriophages φX174 (Ø ~25 nm), PRD1 (Ø ~63 nm), and φ6 (Ø ~71 nm) was studied. φX174 baseline
separates from PRD1 and φ6 with the resolution of ~4 for φX174 and PRD1, whereas the resolution
between PRD1 and φ6 is only ~0.3. Consequently, φX174 is also well separated from the larger viruses
when the viruses were mixed prior to AF4, but the peaks for PRD1 andφ6 merge (Figure 4, yellow line).
The calculated retention levels for φX174, PRD1, and φ6 are ~6, ~14, and ~15, respectively, indicating
good retention. Importantly, it is possible to observe small size differences with AF4 when purified VLP
or virus preparations are compared [21,22,35]. For instance, φ6 particles that lack the P3 surface protein
are well separated from intact virions [35], even though the size difference in radius is only ~2 nm [47],
whereas AF4-MALS studies of purified VLP preparations can detect as small as 1 nm differences in the
radius of gyration [21,22]. Obviously, for highly heterogeneous samples, it is challenging to obtain
narrow and sharp peaks with base line separation for each sample component population. Sometimes
pretreatment of the sample may improve resolution. For example, treatment of culture supernatants
by nucleases may improve separation of viruses from the host-derived complexes [32,35].
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Figure 4. AF4 separation of different-sized spherical bacteriophages. Baseline separation is obtained
for φX174 (ø ~25 nm; gre line) and PRD1 (ø ~63 n ; blue line) r φ6 (ø ~71 nm; orange line) when
analyzed separately. However, PRD1 and φ6 with similar sizes can ot be separated (peak at ~20 min)
when the fractionation is performed for the mixture of φX174, PRD1, and φ6 (yellow line). The
cross-flow gradient is shown with black dashed line (right y-axis). Transition from focusing to elution
is indicated with an arrow. UV detector response is give in volts (V) (left y-axis). A spacer with
250 µm nominal thickness was used. Eluent w s 20 mM Tris-HCl (pH 7.5), 25 mM NaCl. Injected virus
amounts were: φX174 ~1 × 1010 PFU; PRD1 ~1 × 1011 PFU; and φ6 ~1 × 1011 PFU. An RC membrane
with MWCO of 10 kDa and a channel flow rate of 0.3 mL/min was used. V0 is the void peak. The
AF4 instrument used and its operation is described in [32]. Production and purification of viruses is
summarized in Appendix A.
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2.5. Optimization of Focusing and Elution Steps: Flow Rates and Time
At the moment there are two commercial suppliers for the AF4 instruments, Wyatt and Postnova.
The instruments differ in the number of pumps controlling the flow rates and the positions and
numbers of the injection-, focusing-, and purge-flow ports. These differences cause some disparity in
the operation of the instruments and programming of the flows during focusing and elution steps. As
we are familiar with the Postnova instrument, we focus on the principles for regulating the flow rates
therein. Regulation of flow rates in the Wyatt instrument are described in Reference [48].
During focusing, two flows from opposite directions are applied (Figure 5a). In the Postnova
instrument, the sample is injected during the focusing step along the injection flow from the tip flow
port (Figure 5a, blue arrow head). Typical injection-flow rates range from 0.1 to 0.3 mL/min. Focusing
flow is applied from the opposite direction to the injection flow (Figure 5a). The Postnova instrument
has a separate port for the focus flow, whereas the focusing flow is applied from the outlet port in
the Wyatt instrument. In the Postnova setup the focus-flow rate is determined by the set injection,
channel-flow, and cross-flow rates so that Vfocus = Vc + Vout − Vinj. Elution begins by switching off the
focusing flow (Figure 5b). During elution, the incoming tip flow rate is the sum of the set channel-
and cross-flow rates (Vin = Vc + Vout). This applies to the Wyatt instrument as well. The flow rates
contribute to the analysis time, retention, resolution, concentration, and yield, and are thus important
parameters in AF4. The optimized flow rates are always compromises between the analysis time,
dilution, and separation. Notably, as the AF4 method separates virus particles based on the size,
flow rates that are optimized for one virus strain are usually easily modified to suit for other virus
or VLP particles with similar sizes, but are obviously affected by the biochemical properties of the
particle surfaces.
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2.5.1. Focusing Step 
Figure 5. The AF4 experiment is divided into the focusing and elution steps. The pre-stained protein
sample was fractionated to visualize (a) the focusing site (indicated with a white arrow) and (b) the
beginning of elution. (a) During focusing, sample components concentrate into a thin band (here visible
as a blue zone). Focusing is achieved by applying a focusing flow (long black arrow upwards) from an
opposite direction in relation to the incoming tip flow that equals to injection flow during the focusing
step (short black arrow downwards). (b) Switching off the focusing flow (long grey arrow upwards)
initiates elution and sample components start moving towards the outlet end of the channel (here
downwards), the detectors, and the fraction collector according to their sizes. During elution, the tip
flow rate is equal to the sum of channel-flow and cross-flow rates. Ports for the inlet (tip flow in, blue
arrow head) and cross flow (green arrow head) in the Postnova analytical channel are indicated.
2.5.1. Focusing Step
The AF4 experiment initiates with a focusing step that has a dual role. Firstly, it concentrates
the injected sample into a thin zone, preferably less than 5 mm wide, before elution is initiated
(Figure 5a, white arrow) [49]. Secondly, sample components are equilibrated at the distance from the
accumulation wall, which depends on their diffusion properties at the used experimental conditions,
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such as cross flow, temperature, and spacer thickness. This is sometimes referred as sample relaxation.
Focusing is done by applying two opposing flows, the tip and the focusing flow, from the opposite
ends of the channel (Figure 5a). The focusing step is optimized by adjusting the time and flow rates.
Sub-optimal focusing results in poor separation and broad peaks, high intensity void peaks (V0), and
reduced yields (Figure 6a), whereas too long focusing time increases the chance for sample–sample
and sample–membrane interactions that promote aggregation and membrane fouling. The focusing
time is kept as short as possible.
Sample injection takes place during the focusing step. Thus, the focusing time needs to be long
enough to ensure that the sample loop is quantitatively emptied. In practice, the focusing time is
typically ~3−5 times longer than it takes to empty one loop volume. Thus, small sample volumes allow
short focusing times. However, the injected sample volume has little effect in separation as long as the
injected sample amount does not cause overloading [50]. Thus, AF4 is well-suited for the analysis of
dilute samples. There are reports where up to 1 L of dilute environmental sample has been injected to
AF4 [51]. The drawback in analyzing large sample volumes is the long focusing time.
The position of the focusing site is optimized by modifying the injection and focusing flows
(Figures 5a and 6a for an experimental example). Its position affects the effective length of the channel
that can be used for separation (Figure 1). When using the Postnova instrument, adjusting the rates
of the injection flow (Vinj) and the cross flow (Vc) so that their ratio is 0.1 will set the focusing site at
~3.3 cm from the inlet at the site where the breadth of the standard analytical channel is the highest [52].
Spacer thickness has no effect on the focusing site position [52]. Higher Vinj/Vc values result in the
focusing site moving closer to the outlet end of the channel, which can impair resolution and decrease
retention times (Figure 6a).
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Figure 6. Effect of flow rates on separation and retention time. (a) Focusing position (zfoc) affects
retention time. The closer it is to the inlet, the longer is the effective channel length for the separation.
Additionally, the retenti n times increase. (b) An increased cross-flow rate (Vc) promotes equilibration
of sample components into a narrower zone closer to the accumulation wall and retards elution.
(c) Increased channel-flow rate (Vout) promotes elution and shortens the required analysis time, but
may induce dilution. (d) Retention time is unaffected if the ratio of cross-flow and channel-flow rate
(Vc/Vout) is kept constant, whereas resolution and peak intensities can change. Here, increased flow
rates induce virus aggregation, observed as an increase in the intensity of the peak eluting at the end of
the cross-flow gradient. UV detector response is given in volts (V) (left y-axis). Cross-flow gradients
are shown with dashed lines (right y-axis). Transition from focusing to elution is indicated with an
arrow. Injection (Vinj), cross-flow (Vc), and channel-flow (Vout) rates are indicated in the figures. V0 is
the void peak. Spacer with 250 µm nominal thickness was used. Eluent was 20 mM Tris-HCl (pH 7.5),
25 mM NaCl. Injected φ6 amount was ~7 × 1010 PFU corresponding to ~15 µg [34], see Appendix A.
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2.5.2. Elution Step
During elution, the focus flow is switched off and the sample components are separated according
to their hydrodynamic sizes and applied flow rates (Figures 1a and 2). The same cross-flow rate is
applied during the focusing step and the beginning of elution. Cross flow has the strongest effect
on separation (compare Figure 6b,c). A high cross-flow rate improves separation but also promotes
potential sample–sample and sample–membrane interactions, leading to possible aggregation and
reduced yields, as illustrated in Figure 6b,d. High cross-flow rates are usually accompanied with high
channel-flow rates to obtain good and fast separation [13]. Too low cross-flow rate results in poor
resolution, intense void peaks, and broad sample peaks [50]. Due to their large sizes, viruses and VLPs
are generally well retained in the channel, and relatively low cross-flow rates, 0.4 − 1.5 mL/min, yield
good separation (Tables 2 and 3 and references therein; Figures 3, 4 and 6). Retention time is unaltered
as long as the ratio between the cross flow and the channel flow (Vc/Vout) is constant (Figure 6d).
Channel thickness affects the optimal cross-flow rate. If the spacer is changed to a thinner one, a higher
cross-flow rate has to be applied to obtain same resolution.
Elution can be enhanced by applying cross-flow gradients that can vary from constant to linearly
or exponentially decreasing cross-flow rates (see Figures 3 and 6 for examples). Gradients with
decreasing cross-flow force result in continuous decrease in retention and shortened analysis time.
This option can be used to separate small and large sample components in a single experiment in
a reasonable time. For example, linear cross-flow gradients enable the purification of viruses from
cleared culture supernatants in ~60 min [32–34]. However, cross-flow gradients may have a negative
impact on resolution, since sample components of different sizes elute close to each other. In addition,
the selectivity in separation is lost when the cross flow reaches zero. Importantly, virus elution at
the end of the cross-flow gradient can yield homogenous fractions, if the studied samples are free of
aggregates [32–34].
Channel flow (Vout) is kept constant during AF4. It affects the analysis time and separation
efficiency, albeit at a lower level than the cross flow (compare Figure 6b,c). However, high flow rates may
increase sample dilution (Figure 6c), and thus low channel-flow rates enable better detectability [53].
High flow rates increase the amount of liquid waste generated. For genetically modified or pathogenic
viruses and VLPs, generation of large volumes of biohazardous waste can be problematic.
One of the drawbacks of AF4 is the sample dilution that takes place during the separation. In
the channel, the sample components accommodate only a narrow (a few micrometers) space above
the accumulation wall and most of the channel is occupied with eluent only. However, at the channel
outlet, the sample zone becomes mixed with the sample-free eluent and the sample is diluted. Large
sample components, such as virus-sized complexes, are more prone to dilution than are small sample
components [50]. Dilution can be reduced by modifying the flow rates to result in narrow and
high intensity peaks [13,50,53] (Figure 6c) or by utilizing thinner spacers [32]. AF4 purification of
bacteriophage PRD1 from culture supernatants using a 250 µm spacer and a standard analytical
channel resulted in elution of pure virus in comparable concentration to that of the injected input
(dilution factor ~1.5), whereas the use of a 350 µm spacer resulted in ~7-fold dilution [32]. Alternatively,
an additional slot pump that removes the sample-free buffer zone can be utilized to obtain more
concentrated sample fractions.
3. AF4 Applications on Viruses and VLPs
3.1. Virus and VLP Production and Purification
Separation of viruses and VLPs from other sample components in a single AF4 experiment
provides a real-time monitoring tool for virus and VLP production. Such an application can save time
when the production conditions are optimized in terms of maximal yield, quality, or both. Applicability
of AF4 to monitor the release of virions from lytic (bacteriophage PRD1) and non-lytic (archaeal virus
His1) infections by fractionating culture supernatants has been demonstrated [32,33]. For viruses, such
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as His1, with slow-growing hosts, the plaque formation may take several days. Thus, the possibility to
estimate the relative number of viruses directly from the peak area is an obvious benefit. However, the
detection level for the studied viruses was ~109 PFU, which limits the use of this method for viruses
producing a low number of particles. AF4 has also been used for determining the optimal production
time for polyoma JC virus (JCV) VLPs in insect cells [25].
A single optimized AF4 method has been successfully utilized to purify different viruses directly
from cleared culture supernatants of infected cells [32–34]. The “one-step” AF4 purification results in
a virus specimen that has purity comparable with a specimen that is purified to near homogeneity
by three subsequent ultracentrifugations of polyethylene glycol-precipitated viruses. The one-step
AF4 purification has been successfully applied for viruses that have variable sizes, morphologies, and
surface biochemistries (PRD1, φ6, His1, HCIV-1, HRPV-1, and HVTV-1) (Table 3). The collected online
MALS data indicated that the virus-containing fractions contained homogenous particle populations
with expected sizes [32–34]. Importantly, AF4 was successfully used to purify viruses requiring high
ionic strength for virion stability using eluents having up to 1.6 M total ionic strength. This is a technical
advancement, as such conditions are not compatible with ion exchange chromatography [33]. Since
AF4 is based on the hydrodynamic size, separation between mature virions and procapsids having the
same hydrodynamic size cannot be obtained [32]. In such cases, additional purification methods that
are based on density or mass may be needed. Furthermore, natural variation and heterogeneity in the
sizes, e.g., in enveloped and vesicle-like virions, can potentially broaden the peaks in AF4.
3.2. AF4-MALS Analysis of Sample Quality and Quantity
AF4 coupled to MALS detectors has been widely used for the quality analysis of the size, size
distribution, and presence of fragments, oligomers, and aggregates in purified VLP preparations or
to compare the quality of VLPs that derived from different hosts or purification conditions (Table 2
and references therein). AF4-MALS is also applicable to qualitative and quantitative studies of intact
viruses (Table 3 and reference therein). The majority of these studies have utilized purified VLP or virus
preparations (Tables 2 and 3). For example, AF4-MALS was used to obtain information on the size and
size distribution of polyoma virus VLPs assembled from viral capsid proteins having various affinity
tags and on the effect of encapsidated DNA on the assembly and size distribution of VLPs [19,21,22,25].
AF4-MALS has also been used to measure the polydispersity and total virus counts of influenza virus
preparations that were derived from different influenza A and B strains [28,29].
VLP aggregation is often associated with a loss of vaccine potency and their presence may introduce
additional purification needs that influence the yields and increase production costs. Consequently, the
stability of VLPs exposed to storage, pH, freezing and thawing, drying, salinity, or addition of various
formulations such as lyophilization excipients has been studied by AF4-MALS using Qβ VLPs [27],
hepatitis B virus (HBV) VLPs [17], and murine polyoma virus (MPV) VLPs [23]. In addition, the
impact of a production host on HBV VLP aggregation tendency has been studied [17]. The presence of
aggregates, their reversible disaggregation to monomeric viruses, and the effect of added excipients
and temperature on size distribution of influenza viruses has also been successfully examined by
AF4-MALS [28].
3.3. Virus Assembly and Disassembly, and Virion Composition
Understanding the principles of assembly and disassembly are fundamental questions of virology
and also valuable for obtaining high amounts of premium quality VLPs or virions. VLP and virion
assembly relies on the self-assembly properties of subunits and depends on the pH, the presence of
certain cations, the ionic strength, and sometimes on the specific host and/or virus proteins. AF4 has
been used to study the pH and Ca2+ requirements for efficient self-assembly of MPV VLPs [20]. It
was also utilized in methods development where the recovery and homogeneity of VLP preparations
assembled from purified capsomers was improved ~20% by changing the conventional dialysis method
to a simple dilution-based approach promoting self-assembly [24].
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In production of VLPs for therapeutic applications, controlled dissociation of VLPs is often used
to release impurities encapsidated in the VLPs during particle assembly. By using AF4 and eluent
composition preventing reassembly of MPV VLPs, efficient separation of VP1 pentamers that are the
building blocks for VLPs was obtained [19]. AF4-MALS was also used to study the effect of NaCl and
sodium bicarbonate on dissociation of JCV VLPs to VP1 pentamers [25].
AF4 can also be used to analyze the composition of virions and to produce functional subassemblies.
In a recent study, transcriptionally active φ6 nucleocapsids were purified by AF4 fractionation using
particles which were pre-treated with detergent to remove the viral lipid envelope [35]. In addition,
other chemical treatments were performed and their fractionation to soluble sample components
and virion subassemblies were studied using AF4 [35]. In another study, Proteinase K treatment of
HPRV-1 particles prior to AF4 revealed that the observed heterogeneity in particle sizes determined by
AF4-MALS was likely due to differences in the composition of the spike proteins [33] that protrude
from the surface of the vesicle-like virus particles [54]. Importantly, AF4 has potential to be used to
study the nature of complexes formed between virion components, as illustrated by an AF4 study
where dissociation of proteins from the superparamagnetic iron oxide nanoparticles in nonequilibrium
AF4 allowed for differentiation between the slowly and rapidly dissociating nanoparticle protein
complexes [55].
3.4. Other Applications
AF4-MALS has been utilized in an applied environmental virology study, where the effect of viral
biomass on the optical backscattering in oceans was studied [31]. For the calculation of refractive
indexes, the diameters of four viruses (icosahedral phage MS2, Ø ~25-30 nm; icosahedral tailed phage
T4, head Ø ~100 nm; and two new bacteriophage isolates from sea water Y-1, Ø ~50–80 nm, and C-2,
Ø ~110 nm) were determined using AF4 and purified virus specimen.
4. Conclusions
We have summarized the benefits and challenges of the AF4 technique from the perspective of
analyzing and purifying virus-sized macromolecular assemblies (Table 1). One of the key benefits is
indisputably the gentle separation principle that avoids mechanical and shear stress. The other benefit
arises from the readily adjustable eluent composition that can be tailored to maintain the biological
activity of the studied specimen to promote good recovery yields. Alternatively, it can be intentionally
modified to induce controlled dissociation of particles. As the size range of AF4 separation ranges
from nm to µm size ranges, all viruses and VLPs described to date are applicable to AF4 fractionation.
However, the current AF4 research has focused on the study of spherical and tailed viruses only, and
the elution properties of long rod-shaped viruses remains to be studied. The possibility to obtain
online data on the sample quality is an obvious plus. Although obtaining good separation in AF4 can
be tedious, the optimized methods are typically applicable to similarly sized viruses and the analysis
are highly repeatable. Analytical and semi-preparative options as well as automated injection and
fractionation possibilities provide additional benefits that make AF4 an attractive and versatile tool for
studies of viruses and VLPs.
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Appendix A
Virus Sample Preparation for AF4
Bacteriophages φ6, PRD1, and φX174 were cultured and purified as previously described [32,34]
(Table A1). Cell growth was followed by measuring culture turbidity at 550 nm (Chlormic, JP
Selecta S.A., Barcelona, Spain). After lysis, cell debris was removed by centrifugation. Viruses were
precipitated from the cleared lysate using 10% (w/v) polyethylene glycol (PEG) 6000 and 0.5 M NaCl.
Virus precipitates were collected by centrifugation and resuspended in virus specific buffer (~0.01 of
the initial volume; see below). The viruses were purified by rate zonal centrifugation in a linear 5–20%
(w/v) sucrose gradients prepared in virus-specific buffers. Mature infectious viruses were collected by
differential centrifugation and resuspended in virus buffer. Prior to AF4 analysis, aggregated material
was removed by centrifugation at 10,000× g for 5 min.
Table A1. Summary of virus purification.
φ6 PRD1 φX174
Buffer 10 mM K phosphate (pH 7.2),1 mM MgCl2
10 mM K phosphate (pH 7.2),
1 mM MgCl2
50 mM Tris-HCl (pH 7.2),
100 mM NaCl
Lysate clearance ~10,000× g, 20 min, 10 ºC ~10,000× g, 20 min, 10 ºC ~15,000× g, 30 min, 10 ºC
PEG precipitation 10% (w/v) PEG, 0.5 M NaCl 10% (w/v) PEG, 0.5 M NaCl 10% (w/v) PEG, 0.5 M NaCl
Collection of PEG
precipitate ~10,000× g, 20 min, 10 ºC ~10,000× g, 20 min, 10 ºC ~15,000× g, 30 min, 10 ºC
Rate zonal centrifugation 5–20% (w/v)
1, 103,864× g, 50
min, 15 ºC
5–20% (w/v) 1, 103,864×g, 55
min, 15 ºC
5–20% (w/v) 1, 103,864×g, 75
min, 15 ºC
Differential
centrifugation 113,580× g, 3 h, 10 ºC 113,580× g, 3 h, 5 ºC 144,406× g, 2h 20 min, 4 ºC
Given g-values are the max values.
1) linear sucrose gradient
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